Filtra per Last updated date SelectDopoPrimaFrom - To Date Data di conclusione Questa settimana Questo mese Ultima settimana Ultimo mese Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Esito (3828) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA issues advice on use of Lagevrio (molnupiravir) for the treatment of COVID-19 19 Novembre 2021NewsHumanCOVID-19Medicines EMA starts review of Paxlovid for treating patients with COVID-19 19 Novembre 2021NewsHumanCOVID-19Medicines European Antibiotic Awareness Day: Fighting the silent pandemic 18 Novembre 2021NewsHumanVeterinaryCorporateAntimicrobial resistance EMA receives application for marketing authorisation for Xevudy (sotrovimab) for treating patients with COVID-19 18 Novembre 2021NewsHumanCOVID-19Medicines EMA receives application for conditional marketing authorisation of Novavax’s COVID-19 vaccine, Nuvaxovid 17 Novembre 2021NewsHumanCOVID-19Medicines COVID-19: EMA recommends authorisation of two monoclonal antibody medicines 12 Novembre 2021NewsHumanCOVID-19Medicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 November 2021 12 Novembre 2021NewsHumanCOVID-19Medicines First-in-class medicine recommended for treatment of rare blood vessel inflammation 12 Novembre 2021NewsHumanMedicines EMA starts evaluating use of COVID-19 vaccine Spikevax in children aged 6 to 11 10 Novembre 2021NewsHumanCOVID-19Vaccines COVID-19: EMA and Heads of Medicines Agencies update on molnupiravir 8 Novembre 2021NewsHumanCOVID-19Medicines 1 … 54 55 56 57 58 Page 58 of 383 59 60 61 62 … 383
EMA issues advice on use of Lagevrio (molnupiravir) for the treatment of COVID-19 19 Novembre 2021NewsHumanCOVID-19Medicines
EMA starts review of Paxlovid for treating patients with COVID-19 19 Novembre 2021NewsHumanCOVID-19Medicines
European Antibiotic Awareness Day: Fighting the silent pandemic 18 Novembre 2021NewsHumanVeterinaryCorporateAntimicrobial resistance
EMA receives application for marketing authorisation for Xevudy (sotrovimab) for treating patients with COVID-19 18 Novembre 2021NewsHumanCOVID-19Medicines
EMA receives application for conditional marketing authorisation of Novavax’s COVID-19 vaccine, Nuvaxovid 17 Novembre 2021NewsHumanCOVID-19Medicines
COVID-19: EMA recommends authorisation of two monoclonal antibody medicines 12 Novembre 2021NewsHumanCOVID-19Medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 November 2021 12 Novembre 2021NewsHumanCOVID-19Medicines
First-in-class medicine recommended for treatment of rare blood vessel inflammation 12 Novembre 2021NewsHumanMedicines
EMA starts evaluating use of COVID-19 vaccine Spikevax in children aged 6 to 11 10 Novembre 2021NewsHumanCOVID-19Vaccines
COVID-19: EMA and Heads of Medicines Agencies update on molnupiravir 8 Novembre 2021NewsHumanCOVID-19Medicines